Loading…

Cyanidin‐3‐glucoside binds to talin and modulates colon cancer cell adhesions and 3D growth

Cyanidin‐3‐glucoside (C3G) is a natural pigment, found in many colorful fruits and vegetables. It has many health benefits, including anti‐inflammation, cancer prevention, and anti‐diabetes. Although C3G is assumed to be an antioxidant, it has been reported to affect cell‐matrix adhesions. However,...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2020-02, Vol.34 (2), p.2227-2237
Main Authors: Baster, Zbigniew, Li, Liqing, Kukkurainen, Sampo, Chen, Jing, Pentikäinen, Olli, Győrffy, Balázs, Hytönen, Vesa P., Zhu, Haining, Rajfur, Zenon, Huang, Cai
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cyanidin‐3‐glucoside (C3G) is a natural pigment, found in many colorful fruits and vegetables. It has many health benefits, including anti‐inflammation, cancer prevention, and anti‐diabetes. Although C3G is assumed to be an antioxidant, it has been reported to affect cell‐matrix adhesions. However, the underlying molecular mechanism is unknown. Here, we show that the expression of talin1, a key regulator of integrins and cell adhesions, negatively correlated with the survival rate of colon cancer patients and that depletion of talin1 inhibited 3D spheroid growth in colon cancer cells. Interestingly, C3G bound to talin and promoted the interaction of talin with β1A‐integrin. Molecular docking analysis shows that C3G binds to the interface of the talin‐β‐integrin complex, acting as an allosteric regulator and altering the interaction between talin and integrin. Moreover, C3G promoted colon cancer cell attachment to fibronectin. While C3G had no significant effect on colon cancer cell proliferation, it significantly inhibited 3D spheroid growth in fibrin gel assays. Since C3G has no or very low toxicity, it could be potentially used for colon cancer prevention or therapy.
ISSN:0892-6638
1530-6860
DOI:10.1096/fj.201900945R